ALS meets RNAi
نویسندگان
چکیده
منابع مشابه
Virus meets RNAi
Introduction Small rnas are important regulators of gene expression that operate through a range of rna-silencing mechanisms. of these, rna interference (rnai)—gene silencing through small-interfering rnas (sirnas) derived from exogenous double-stranded rna (dsrna)—and the microrna (mirna) pathway—gene silencing guided by small rnas encoded in the genome—are the best known. the discovery that d...
متن کاملInvestigating Modifiers of Als Toxicity through a Genome Wide Rnai Screen of C. Elegans
INTRODUCTION Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease, afflicts over 400,000 people worldwide, making it the most common neuromuscular disease [1]. It is an age-dependent disease that usually onsets around age 50, though symptoms develop differently in each individual [1]. ALS is characterized by a deterioration of motor neurons that leads to paralysis and eventua...
متن کاملAsian Citrus Psyllid RNAi Pathway – RNAi evidence
Diaphorina citri, known as the Asian citrus psyllid, is an important pest of citrus because it transmits a phloem-limited bacteria strongly implicated in huanglongbing (citrus greening disease). Emerging biotechnologies, such as RNA interference, could provide a new sustainable and environmentally friendly strategy for the management of this pest. In this study, genome and functional analysis w...
متن کاملBacterial Delivery of RNAi Effectors: Transkingdom RNAi
RNA interference (RNAi) represents a high effective mechanism for specific inhibition of mRNA expression. Besides its potential as a powerful laboratory tool, the RNAi pathway appears to be promising for therapeutic utilization. For development of RNA interference (RNAi)-based therapies, delivery of RNAi-mediating agents to target cells is one of the major obstacles. A novel strategy to overcom...
متن کاملNerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.
RNA interference (RNAi) mediates sequence-specific gene silencing, which can be harnessed to silencing disease-causing genes for therapy. Particularly suitable diseases are those caused by dominant, gain-of-function type of gene mutations. In these diseases, the mutant gene generates a mutant protein or RNA product, which possesses toxic properties that harm cells. By silencing the mutant gene,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Neuroscience
سال: 2005
ISSN: 1471-003X,1471-0048
DOI: 10.1038/nrn1656